Goldman Sachs Group Inc Bicycle Therapeutics PLC Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$20.02 - $24.69 $831,690 - $1.03 Million	-41,543 Reduced 74.92%	13,907 $281,000
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $928,787 - $1.45 Million	55,450 New	55,450 $1.38 Million
Q2 2023 May 14, 2024	BUY	$18.95 - $28.67 $145,289 - $219,812	7,667 Added 72.69%	18,215 $464,000
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $145,289 - $219,812	7,667 Added 72.69%	18,215 $464,000
Q1 2023 May 14, 2024	SELL	$20.02 - $31.37 $1.4 Million - $2.2 Million	-70,005 Reduced 86.91%	10,548 $224,000
Q1 2023 May 11, 2023	SELL	$20.02 - $31.37 $1.4 Million - $2.2 Million	-70,005 Reduced 86.91%	10,548 $224,000
Q4 2022 May 14, 2024	SELL	$20.37 - $32.9 $503,913 - $813,880	-24,738 Reduced 23.49%	80,553 $2.38 Million
Q4 2022 Feb 13, 2023	SELL	$20.37 - $32.9 $503,913 - $813,880	-24,738 Reduced 23.49%	80,553 $2.38 Million
Q3 2022 May 14, 2024	SELL	$17.49 - $28.44 $857,622 - $1.39 Million	-49,035 Reduced 31.77%	105,291 $2.45 Million
Q3 2022 Nov 10, 2022	SELL	$17.49 - $28.44 $857,622 - $1.39 Million	-49,035 Reduced 31.77%	105,291 $2.45 Million
Q2 2022 May 14, 2024	BUY	$12.95 - $46.99 $2 Million - $7.25 Million	154,326 New	154,326 $2.59 Million
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $115,760 - $420,043	-8,939 Reduced 5.48%	154,326 $2.59 Million
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $5.72 Million - $8.48 Million	142,578 Added 689.22%	163,265 $7.16 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $242,860 - $356,079	5,824 Added 39.18%	20,687 $1.26 Million
Q3 2021 Nov 10, 2021	BUY	$27.95 - $44.24 $415,420 - $657,539	14,863 New	14,863 $618,000

Others Institutions Holding BCYC

# of Institutions

111

Shares Held

40.8M

Call Options Held

39.6K

Put Options Held

24.6K

Baker Bros. Advisors LP New York, NY

9.4M
Shares

$138 Million
2.28% of portfolio
Deep Track Capital, LP Greenwich, CT

3.55M
Shares

$52.1 Million
2.97% of portfolio
Fcpm Iii Services B.V. Naarden, P7

2.34M
Shares

$34.4 Million
9.09% of portfolio
Ra Capital Management, L.P. Boston, MA

2.25M
Shares

$33.1 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

1.96M
Shares

$28.7 Million
0.74% of portfolio

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account